arrow
K

Konstantin A. Krychtiuk

Medical University of Vienna
H指数:27
被引数:6,906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Threshold-Based Eligibility for Emerging Lipoprotein(a)-Targeted Therapies in Chronic and Acute Coronary Syndrome

基于真实世界阈值的脂蛋白(a)靶向疗法在慢性与急性冠状动脉综合征中的适用性

2026-09-250
PRE
The SLCO1B1 c.521 T>C variant (rs4149056) is not associated with muscular symptoms or PCSK9-inhibitor prescription in patients with severe hypercholesterolemia and contemporary lipid lowering therapy

SLCO1B1 c.521 T>C变异(rs4149056)与严重高胆固醇血症患者伴当代降脂治疗者的肌肉症状或PCSK9抑制剂处方无关联。

2026-03-300
OAAI
ESC quality indicators for post-myocardial infarction care: transition and chronic coronary syndrome phases: Developed in collaboration with the European Association of preventive cardiology of the ESC

欧洲心脏病学会(ESC)心肌梗死后护理质量指标:过渡期和慢性冠状动脉综合征阶段:由ESC欧洲预防心脏病学协会合作制定

2025-12-040
PRE
Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension

克服开发与实施新型高血压疗法的障碍

2025-10-010
PRE
Haemodynamic monitoring and management of the hypotensive out-of-hospital cardiac arrest patient in the adult intensive care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the ESC

血流动力学监测和管理在成人重症监护病房中的低血压院外心脏骤停患者:欧洲急症心血管护理协会临床共识声明

2025-09-270
PRE
High-sensitivity point-of-care measurement of cardiac troponin

高敏床旁测量心脏肌钙蛋白

2025-08-010
OA
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective

心血管-肾脏-代谢疾病循证疗法的实施进展:多利益相关方视角

2025-05-070
PRE